AU2003249999A8 - 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours - Google Patents

1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours

Info

Publication number: AU2003249999A8
Authority: AU; Australia
Prior art keywords: tetraazacyclododecanes; guanine; modulators; binding protein; treating tumours
Prior art date: 2002-07-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Inventor

Hans Robert Kalbitzer

Burkhard Konig

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-10

Filing date

2003-07-09

Publication date

2004-02-02

2002-08-29Priority claimed from DE10239612Aexternal-prioritypatent/DE10239612A1/en

2003-07-09Application filed by IndividualfiledCriticalIndividual

2004-02-02Publication of AU2003249999A8publicationCriticalpatent/AU2003249999A8/en

2004-02-02Publication of AU2003249999A1publicationCriticalpatent/AU2003249999A1/en

StatusAbandonedlegal-statusCriticalCurrent

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2003249999A2002-07-102003-07-091,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumoursAbandonedAU2003249999A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
DE10231270		2002-07-10
DE10231270.2		2002-07-10
DE10239612ADE10239612A1 (en)	2002-07-10	2002-08-29	Methods and connections for influencing the spatial structure of GNB proteins
DE10239612.4		2002-08-29
PCT/EP2003/007367WO2004006934A2 (en)	2002-07-10	2003-07-09	1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours

Publications (2)

Publication Number	Publication Date
AU2003249999A8true AU2003249999A8 (en)	2004-02-02
AU2003249999A1 AU2003249999A1 (en)	2004-02-02

Family

ID=30116624

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003249999AAbandonedAU2003249999A1 (en)	2002-07-10	2003-07-09	1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours

Country Status (2)

Country	Link
AU (1)	AU2003249999A1 (en)
WO (1)	WO2004006934A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101106433B1 (en)*	2009-04-03	2012-01-18	서울대학교산학협력단	Macrocyclic Amino Acid Derivatives and Radioactive or Nonradioactive Metal Labeling Compounds for Targeting Cancer Tissues
EP2671575A1 (en)	2012-06-04	2013-12-11	Universität Regensburg	Ras inhibitors
WO2014153624A1 (en)*	2013-03-28	2014-10-02	The University Of Sydney	Antibacterial compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3640708C2 (en)*	1986-11-28	1995-05-18	Schering Ag	Improved pharmaceuticals containing metals
DE4009119A1 (en)*	1990-03-19	1991-09-26	Schering Ag	1,4,7,10-TETRAAZACYCLODODECANE-BUTYLTRIOLS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM
US5272056A (en)*	1991-01-03	1993-12-21	The Research Foundation Of State University Of New York	Modification of DNA and oligonucleotides using metal complexes of polyaza ligands
DE19603033A1 (en)*	1996-01-19	1997-07-24	Schering Ag	Perfluoroalkyl-containing metal complexes, processes for their preparation and their use in NMR diagnostics
DE19608278A1 (en)*	1996-02-23	1997-08-28	Schering Ag	Pharmaceutical compositions containing perfluoroalkyl-containing metal complexes, and their use in tumor therapy and interventional radiology
DE19641197C2 (en)*	1996-09-24	1999-02-18	Schering Ag	Ion pairs and their use as contrast agents
DE19719033C1 (en)*	1997-04-29	1999-01-28	Schering Ag	Ion pairs, processes for their preparation and their use as contrast agents
WO2000021941A1 (en)*	1998-10-13	2000-04-20	Synchem Reserach, Inc.	Biomimetic chelating agents and methods
DE19849465A1 (en)*	1998-10-21	2000-04-27	Schering Ag	New dimeric ion pairs containing cationic and anionic metal complexes; useful as low viscosity contrast agents for X-ray, magnetic resonance and radiodiagnostic techniques, and as radiotherapy agents
JP2003516984A (en)*	1999-12-17	2003-05-20	アノーメッド・インコーポレイテッド	Heterocyclic compounds that bind chemokine receptors
EP1273658A4 (en)*	2000-03-30	2004-08-11	Takeda Chemical Industries Ltd	NOVEL PROTEIN, DNA ENCODING THE SAME, AND PROCESS FOR PRODUCING THE SAME
AU2001286644A1 (en)*	2000-08-25	2002-03-13	Genaissance Pharmaceuticals, Inc.	Haplotypes of the gng7 gene
DE10104389A1 (en)*	2001-01-19	2002-08-01	Schering Ag	New multimeric photosensitizer, useful in photodynamic therapy of cancers and other angiogenic conditions, can also be conjugated with e.g. protein, antibody or oligonucleotide

2003
- 2003-07-09AUAU2003249999Apatent/AU2003249999A1/ennot_activeAbandoned
- 2003-07-09WOPCT/EP2003/007367patent/WO2004006934A2/ennot_activeApplication Discontinuation

Also Published As

Publication number	Publication date
WO2004006934A2 (en)	2004-01-22
WO2004006934A3 (en)	2004-04-01
AU2003249999A1 (en)	2004-02-02

Similar Documents

Publication	Publication Date	Title
IL164533A0 (en)	2005-12-18	Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
AU2003299791A1 (en)	2004-07-22	Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
PL375532A1 (en)	2005-11-28	Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
AP2006003525A0 (en)	2006-02-28	Ä1,8ÜNapthyridin-2-ones and related compounds for the treatment of schizophrenia.
GB0512560D0 (en)	2005-07-27	Bioreactors for well treatment
AP2210A (en)	2011-02-25	4-tetrazolyl-4phenylpiperidine derivatives for treating pain.
ZA200409492B (en)	2006-02-22	Compositions and methods for the diagnosis and treatment of tumor.
AU2003218767A1 (en)	2003-10-27	Fabric treatment composition
IL164896A0 (en)	2005-12-18	Immunoconjugates for the treatment of tumours
IL169633A0 (en)	2007-07-04	Combination therapy for treating protein deficiencies
EP1572118A4 (en)	2010-07-14	Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216
EP1442062A4 (en)	2005-11-09	Methods for the treatment of carcinoma
AU2003290059A1 (en)	2004-07-09	Use of cd137 antagonists for the treatment of tumors
PL377464A1 (en)	2006-02-06	Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders
EP1551388A4 (en)	2009-07-15	Compounds useful for the treatment of cancer, compositions thereof and methods therewith
MXPA03007314A (en)	2003-12-04	Improved skin composition.
IL162818A0 (en)	2005-11-20	Combination therapy for the treatment of bacterialinfections
AP2004003070A0 (en)	2004-06-30	The method of treating cancer.
ZA200501288B (en)	2005-09-05	Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
AU2003223538A1 (en)	2003-10-27	Methods for the treatment of cancer
LT1496918T (en)	2023-05-25	Use of sodium meta-arsenite for the treatment of tumours
AU2002304883A1 (en)	2003-05-08	Device for the treatment of tumours
AU2003296545A1 (en)	2004-07-09	Use of a trpm8-activating substance for the treatment of tumours
AU2003249999A8 (en)	2004-02-02	1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours
AU2003232108A8 (en)	2003-11-11	1,1- and 1,2-bisphosphonates as apoliprotein e modulators

Legal Events

Date	Code	Title	Description
2005-04-07	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase

Movatterモバイル変換